Adding Apalutamide Boosts PSA Control in Prostate Cancer ...Middle East

Medscape - News
Adding apalutamide to androgen deprivation therapy (ADT) prolongs prostate-specific antigen progression-free survival in patients with biochemically recurrent prostate cancer. Medscape Medical News

Hence then, the article about adding apalutamide boosts psa control in prostate cancer was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Adding Apalutamide Boosts PSA Control in Prostate Cancer )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News